Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. OBJECTIVE: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. DESIGN: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. SETTING: The study was conducted at the University "Magna Graecia" of Catanzaro, Catanzaro, Italy. PATIENTS: One hundred nonobese primary infertile anovulatory women with PCOS participated. INTERVENTIONS: We administered metformin cloridrate (850 mg twice daily) plus placebo (group A) or placebo plus CC (150 mg for 5 d from the third day of a progesterone withdrawal bleeding) (group B) for 6 months each. MEAN OUTCOME MEASURES: The main outcome measures were ovulation, pregnancy, abortion, and live-birth rates. RESULTS: The subjects of groups A (n = 45) and B (n = 47) were studied for a total of 205 and 221 cycles, respectively. The ovulation rate was not statistically different between either treatment group (62.9 vs. 67.0%, P = 0.38), whereas the pregnancy rate was significantly higher in group A than group B (15.1 vs. 7.2%, P = 0.009). The difference found between groups A and B regarding the abortion rate was significant (9.7 vs. 37.5%, P = 0.045), whereas a positive trend was observed for the live-birth rate (83.9 vs. 56.3%, P = 0.07). The cumulative pregnancy rate was significantly higher in group A than group B (68.9 vs. 34.0%, P < 0.001). CONCLUSIONS: Six-month metformin administration is significantly more effective than six-cycle CC treatment in improving fertility in anovulatory nonobese PCOS women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“None of the currently available human insulin preparations have been demonstrated to cross the placenta (93-98).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Nugent, D., Vanderkerchove, P., Hughes, E., Arnot, M., & Lilford, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000410.pub2 · Cited by 80
RetractedClomiphene citrate for ovulation induction in women with oligo-amenorrhoea
Hughes, E. G., Collins, J. A., & Vandekerckhove, P. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000056 · Cited by 75
Retracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1502 · Cited by 789
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786
Cited by
Items 201–279 of 279
Font, T. P., Ampudia‐Blasco, F. J., & Carmena, R. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71130-5 · Cited by 2
Barnes, R. B. (2006) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)70421-1 · Cited by 2
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2014) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2014.20.22-35 · Cited by 2
Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort
Reinauer, C., Bollow, E., Fröhlich-Reiterer, E. E., Laubner, K., Bergis, D., Schöfl, C., Kempe, H., Hummel, M., Hennes, P., Gollisch, K. S. C., et al. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104701 · Cited by 2
“There might be a benefit in fertility treatment, where metformin can be added to clomiphene or used alone [26, 27] and therefore a subgroup of the women in our cohort will use metformin not only for improvement of metabolic control but also to induce pregnancy.”
BackgroundReply: Metformin in therapy naive patients with polycystic ovary syndrome
Moll, E., & van der Veen, F. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmm050 · Cited by 1
Tratamiento del síndrome del ovario poliquístico con sensibilizantes a la insulina y antiandrógenos
Moghetti, P. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71169-x · Cited by 2
Baillargeon, J., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_18 · Cited by 2
Using evidence from randomized trials in fertility practice
Hughes, E. G. (2007) · Human Fertility · doi:10.1080/14647270600917263 · Cited by 1
“Turning to MEDLINE, a search using ‘metformin’ and ‘polycystic*’ as keywords and ‘randomized controlled trial’ as a limiting factor, yields 28 studies, one of which is a recent RCT comparing metformin with clomiphene as first line therapy for slim PCO patients (Palomba et al., 2005).”
Polycystic Ovary Syndrome: Its Genetics and Treatments
Tripathy, S., Roy, C., & Banerjee, A. (2022) · INDIAN JOURNAL OF PHYSIOLOGY AND ALLIED SCIENCES · doi:10.55184/ijpas.v72i1.29 · Cited by 3
Kunnath, A. N., Parker, S. K., Crasta, D. N., Kunhiraman, J. P., Madhvacharya, V. V., Kumari, S., Nayak, G., Vani Lakshmi, R., Modi, P. K., Prasad, T. S. K., et al. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117039 · Cited by 3
The Current Status for Metformin Use in Reproductive Medicine
Legro, R. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_12 · Cited by 1
“... a per cycle of fecundity of 40% or greater by the end of the trial, whereas clomiphene declined dismally to 0%. In the follow-up, smaller clinical trial (N = 80 subjects) by the same group that looked at of metformin vs. clomiphene as first line therapy for infertility in women with PCOS, the investigators found n…”
BackgroundResultInfluentialSyndrom der polyzystischen Ovarien (PCOS)
Weiss, J. M., Hadžiomerović, D., & Kreienberg, R. (2008) · Der Gynäkologe · doi:10.1007/s00129-008-2123-y · Cited by 2
Role of Insulin-Sensitizing Drugs in PCOS Management
Awwad, J. T., & Ghazeeri, G. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_10 · Cited by 2
Traitements adjuvants en stimulation ± insémination
Alvarez, S. (2010) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(10)70010-2 · Cited by 1
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Han, C. S., & Werner, E. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_15 · Cited by 1
Ornoy, A., & Weber-Schöndorfer, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00016-0 · Cited by 1
Lombardi, L. A., Mattos, L. S., Moura, M. L. A., Espíndula, A. P., Simões, R. S., Florencio‐Silva, R., Simões, M. D. J., Franco, P. C., Sasso, G. R. D. S., & Soares, J. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i6.15536 · Cited by 2
“…in those patients (Speroff & Fritz, 2005) Several authors have describe the effectiveness of treating infertility using insulin sensitizers such as metformin alone or in combination with other drugs including clomiphene citrate (Nestler et al., 1998; Vandermolen et al., 2001; Palomba et al., 2005).”
BackgroundUse of Insulin Sensitizers in the Polycystic Ovary Syndrome
Cheang, K. I., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_38 · Cited by 1
“For example, metformin may need to be administered throughout the pregnancy, only during the first trimester, or only during conception to confer maximal protection, as suggested by two recent studies by Palomba et al. ( 24 ,27).”
MethodShapiro, A. J., Kushnir, V. A., & Seifer, D. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_25 · Cited by 1
Pregnancy in Polycystic Ovary Syndrome
Homburg, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_20 · Cited by 1
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10002-0 · Cited by 1
“In einigen Studien konnte eine Senkung der Abortrate durch Metformin bei Frauen mit einem PCOS nachgewiesen werden (Sohrabvand et al. 2009; Palomba et al. 2005; Jakubowicz et al. 2002).”
Abou-Seido, N., Yaqub, M., & Desouza, A. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.476 · Cited by 2
Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Clínicas médicas de Norteamérica · doi:10.1016/s0186-0194(08)92058-x · Cited by 2
Anwendung von Clomifen zur ovariellen Stimulation
Nawroth, F. (2007) · Gynäkologische Endokrinologie · doi:10.1007/s10304-006-0169-2 · Cited by 1
Polycystic ovary syndrome and fertility
Goldenberg, N., & Glueck, C. J. (2013) · doi:10.2217/ebo.12.175 · Cited by 1
Abstracts and workshop summaries
(2006) · Human Fertility · doi:10.1080/14647270600772163 · Cited by 1
Reproductive and Obstetrical Consequences of the Polycystic Ovary Syndrome
Johnson, M. C., & Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_30
Santonocito, V. C., Rapisarda, V., Abruzzo, S. R. M., Pollicino, R., Coco, L., & Zarbo, G. (2009) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
Kinzler, C. (2009) · CommonKnowledge Research Repository (Pacific University Oregon)
Magan, N. (2010) · ResearchSpace (University of KwaZulu-Natal)
Syndrom der polyzystischen Ovarien (PCOS) – Diagnostik und Therapie
Hadžiomerović, D., Kreienberg, R., & Weiss, J. M. (2007) · Der Gynäkologe · doi:10.1007/s00129-007-2003-x
Das PCOS – aktuelle endokrine und klinische Aspekte
Schorsch, M., Heidner, C., Gomez, R., Skala, C., von Hahn, T., & Seufert, R. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Störungen des Androgenhaushalts
Weiss, J. M. (2009) · Springer eBooks · doi:10.1007/978-3-540-89760-6_16
Metabolic Complications of Polycystic Ovary Syndrome
Setji, T. L., & Brown, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_23 · Cited by 1
“There is evidence from observational studies (82,83) and a recent randomized controlled trial that metformin decreases spontaneous abortion rates ( 84 ).”
BackgroundAKÇELİK, Y., Çöğendez, E., Şilfeler, D. B., Eken, M. K., & Karakaya, S. (2015) · Turkiye Klinikleri Journal of Gynecology and Obstetrics · doi:10.5336/gynobstet.2014-41444 · Cited by 1
Uso de la metformina en pacientes con el síndrome del ovario poliquístico
Morales, D. F., & Verdesia, F. S. (2009) · Acta Médica Costarricense · doi:10.51481/amc.v49i3.318 · Cited by 2
Jahan, P., Giasuddin, A. S. M., & Haq, A. M. M. (2012) · Sri Lanka Journal of Obstetrics and Gynaecology · doi:10.4038/sljog.v33i3.4017 · Cited by 2
Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x
Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8 · Cited by 1
Wang, X., Wang, J., Xu, Y., & Huang, L. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4022-0
Reply: Polycystic ovary-related miscarriage—should metformin be proposed to such frustrated women?
Jauniaux, E. R. M., Farquharson, R. G., Christiansen, O. B., & Exalto, N. (2006) · Human Reproduction · doi:10.1093/humrep/del387
Une alternative pour traiter l’infertilité : le drilling ovarien
Fernandez, H. (2009) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(09)71513-9
Aktuelle Therapieansätze für das PCO-Syndrom bei Insulinresistenz
Ludwig, M. Z. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Polycystic ovary-related miscarriage: should metformin be proposed to such frustrated women?
Manno, M., Tomei, F., & Marchesan, E. (2006) · Human Reproduction · doi:10.1093/humrep/del386 · Cited by 1
“With a PubMed search, we found at least 18 articles on metformin-PCO and abortion as key words; between these articles, at least five (Gluek et al., 2001, 2002; Jabukowicz et al., 2002; Palomba et al., 2005; Thatcher and Jackson, 2006) suggest that metformin is able to reduce miscarriage rate in polycystic ovary syndr…”
BackgroundMethodMachado, A. D. B. (2013) · Americanae (AECID Library) · Cited by 1
Siebert, T. I. (2008) · SUNScholar (Stellenbosch University)
Effective Regimens for Ovulation Induction in Polycystic Ovary Syndrome
Tapanainen, J. S., & Morin-Papunen, L. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_19 · Cited by 1
“Prospective randomized controlled studies have shown a significant fourfold decrease (9.7 vs. 37.5%) in miscarriage rates compared with CC treatment in non-obese women with PCOS ( 56 ) and a twofold decrease (15.4 vs. 29.0%) compared with laparoscopic ovarian drilling (LOD) in obese women with PCOS (70).”
BackgroundResultInfluentialTreatment of Infertility in the Polycystic Ovary Syndrome
Stewart, A. (2007)
Alvarez, S. (2007) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2007.07.014
Achieving pregnancy in the anovulatory woman
Legro, R. S., & Dokras, A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.020
Members of the Special Advisory Commission on Mandated Health Insurance Benefits
Cox, D. M. K., Colgan, C. J., Griffith, D. H. M., Hamilton, P. A., Frank, D., Hargrove, D. M., Houck, S. R. E., Howell, J. D., Johnny, D., Joannou, S., et al. (2008)
Majeed, B. M., & Saleh, R. A. (2012) · The Medical Journal of Tikrit University
Metformin: direct inhibition of rat ovarian theca-interstitial cell
Palaniappan, M., Peegel, H., & Kayampilly, P. P. (2012)
Fertility Treatment for Women with PCOS
Langdon, F., Pontré, J., & Hart, R. J. (2017) · InTech eBooks · doi:10.5772/intechopen.71188 · Cited by 2
Palomba, S., Falbo, A. I., & Sala, G. B. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_11
Griesinger, G. (2010) · Gynäkologische Endokrinologie · doi:10.1007/s10304-010-0379-5
Mazumder, H., Faizah, F., & Hossain, M. M. (2020) · medRxiv · doi:10.1101/2020.01.23.20018580
Rodríguez‐Pinilla, E., & Weber-Schöndorfer, C. (2007) · Elsevier eBooks · doi:10.1016/b978-0-444-52072-2.50019-7
FACTORS AFFECTING METFORMIN AND CLOMIPHENE’S REPRODUCTIVE EFFICACY IN PCOS WOMEN
Poushuju, R. J., El‐Mallah, A., Soubra, L. T., & Jarrah, L. N. (2020) · BAU Journal - Health and Wellbeing · doi:10.54729/2789-8288.1035
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2006) · Elsevier eBooks · doi:10.1016/b978-343721332-8.50004-1
Gibson, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1436-1_35
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Holliman, K., Wu, E., & Han, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_16
Role of Insulin-Sensitizing Drugs in PCOS Management
Kojok, D., Ghazeeri, G. S., & Awwad, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_12 · Cited by 1
Shoham, Z., & Howles, C. M. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841849737.037 · Cited by 1
Pharmacotherapeutic Management
Dunning, T. L., & Glenn Ward MBBS, B. (2008) · doi:10.1002/9780470697672.ch5
Meikle, A. W. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79301-5
Schurman, L., González, C. D., Leiderman, S. M., Calvar, C. E., Curriá, M., Fernández, G. I., Otta, C. F., & Llano, M. (2016) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2016.05.008 · Cited by 2
Falcone, T. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00195-8
New pharmacotherapeutic aspects associated with the use of Metformin
Tanushevska, I., Grozdanova, A., Nestorovska, A. K., Naumovska, Z., Dimkovski, A., Mihajloska, E., & Sterjev, Z. (2022) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2022.68.03.237
Chakraborty, A., Dwibedi, D., Das, C., & Ghosh, D. (2023) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2023.041
Review on Polycystic Ovarian Syndrome (PCOS) In Case of Pregnancy
-, T. G. N., -, D. G. A., -, T. M. S., & -, S. P. J. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i05.8005
Oliveira, P. S., Uggioni, M. L. R., Colonetti, T., Balbinot, E. L., Marçal, F., Silveira, V., Rech, P., Macedo, A. C. L., Ceretta, L. B., Grande, A. J., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4781337
Syndrome des ovaires polykystiques
Hugues, J. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_17
Peng, G., Yan, Z., Liu, Y., Li, J., Ma, J., Tong, N., & Wang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22619125
IMPACT OF INSULIN RESISTANCE ON REPRODUCTIVE OUTCOMES IN WOMEN WITH PCOS
Hlukhava, Y., Skadorva, N., Gursky, V. V., Bohdzel, M., Babkova, K., Ilina, I., Korpacka, A., Borowiecka, P. A., Proborshch, P., & Sazon, R. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5515
The Effect of PCOS on Fertility and Pregnancy
Salley, K. E. S., & Nestler, J. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_10
Metadata
- Authors
- Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F.
- Affiliations
- Magna Graecia University (IT)
- Departments of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., A.C.), 80138 Naples, Italy;
- Internal Medicine (F.M.), 80138 Naples, Italy;
- Federico II University Hospital (IT)
- University of Palermo (IT)
- Corresponding author
- Palomba, Stefano
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 4068-4074
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126438731
- Cited by
- 279
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 10 · 2013: 18 · 2012: 17
- FWCI
- 35.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- polycystic ovary syndrome, clomiphene citrate, metformin, ovulation induction, anovulation, infertility, pregnancy rate, live birth rate, abortion rates, non-obese women, first-line therapy, ovulation rate, cumulative pregnancy rate, insulin sensitizers, ovulation-inducing drugs
- MeSH terms
- Adult, Anovulation, Clomiphene, Double-Blind Method, Female, Humans, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.